Paranovus Entertainment Technology Ltd.
PAVSHealthcare|Medical - Pharmaceuticals|US
$2.93
+0.12 (+4.27%)
DCF Value
$2110.33
Tangible Book / Share
$10424.75
Cash / Share
$9520.71
Financials
Financial Snapshot
Market Cap
$2.5M
Enterprise Value
-$7.1M
Revenue (TTM)
$14.7M
Net Income (TTM)
-$20.3M
Cash & Investments
$15.3M
Net Cash
$14.5M
Free Cash Flow (TTM)
-$4.1M
Operating CF (TTM)
-$4.1M
Debt/Equity
0.02
Cash Runway & Burn Rate
Cash on Hand
$15.3M
Quarterly Burn
$1.0M
Monthly Burn
$339.1K
Est. Runway
~15.0 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $4.3M | $8.9M | $14.8M | $33.7M | $36.6M | $19.7M | $2.0M | $341.8K | $5.0M | $15.3M | $15.3M | |
| Operating Cash Flow | $11.3M | $12.9M | $6.5M | $10.8M | $2.9M | -$28.1M | -$3.0M | -$13.1M | -$2.7M | -$1.4M | -$4.1M | |
| Free Cash Flow | $10.2M | $12.8M | $6.3M | $9.6M | $121.0K | -$30.5M | -$3.0M | -$13.1M | -$2.7M | -$1.4M | -$4.1M | |
| Capital Expenditure | -$1.1M | -$158.0K | -$283.1K | -$1.2M | -$2.8M | -$2.4M | $0.00 | $0.00 | -$4.00 | $0.00 | -$3.00 | |
| Financing Cash Flow | -$8.4M | -$8.8M | $271.1K | $10.4M | $10.6M | $18.8M | $3.1M | $0.00 | $29.0M | $15.6M | $44.6M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.0M | $61.5M | $63.9M | $65.1M | $71.5M | $89.5M | $23.3M | $0.00 | $71.5K | $14.6M | $14.7M | |
| Cost of Revenue | $27.2M | $32.1M | $31.7M | $34.6M | $53.3M | $85.8M | $22.9M | $380.0K | $442.5K | $12.2M | $14.9M | |
| Gross Profit | $25.8M | $29.4M | $32.2M | $30.4M | $18.2M | $3.7M | $416.9K | -$380.0K | -$371.0K | $2.4M | -$219.2K | |
| R&D | $1.7M | $1.9M | $2.2M | $2.4M | $1.7M | $1.7M | $1.4M | $0.00 | $0.00 | $0.00 | $0.00 | |
| SG&A | $7.0M | $7.3M | $8.2M | $12.7M | $15.0M | $49.6M | $5.0M | $2.1M | $1.9M | $5.8M | $5.5M | |
| Operating Income | $17.2M | $20.2M | $21.8M | $15.4M | $1.5M | -$47.6M | -$4.5M | -$2.5M | -$2.3M | -$3.4M | -$5.7M | |
| Interest Expense | $493.7K | $133.3K | $83.5K | $98.1K | $111.8K | $86.0K | $72.3K | $39.2K | $261.9K | $262.5K | $524.4K | |
| Pretax Income | $17.0M | $20.4M | $21.9M | $15.5M | $1.7M | -$57.7M | -$4.5M | -$4.3M | -$7.0M | -$14.5M | -$21.5M | |
| Net Income | $14.5M | $17.5M | $18.7M | $12.7M | $786.4K | -$49.2M | -$71.7M | -$17.7M | -$7.5M | -$12.7M | -$20.3M | |
| EPS (Diluted) | 1377.00 | 1659.10 | 1797.30 | 1277.10 | 72.14 | -2916.00 | -1516.10 | -448.12 | -10.69 | -2207.28 | -7542.14 | |
| EBITDA | $17.3M | $20.4M | $22.5M | $16.1M | $2.4M | -$45.4M | -$4.5M | -$2.1M | -$1.9M | -$12.0M | -$3.0M | |
| Shares Out. (M) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.04 | 0.70 | 0.01 | 0.00 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.3M | $8.9M | $14.8M | $33.7M | $36.6M | $19.7M | $2.0M | $341.8K | $261.4K | $10.3M | $10.3M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.8M | $5.0M | $5.0M | |
| Total Current Assets | $32.2M | $43.8M | $54.8M | $70.0M | $95.1M | $56.6M | $9.8M | $2.9M | $7.2M | $20.2M | $20.2M | |
| Total Assets | $41.5M | $53.4M | $65.7M | $85.1M | $112.7M | $97.4M | $36.3M | $7.7M | $35.6M | $36.9M | $36.9M | |
| Total Current Liabilities | $18.0M | $8.8M | $4.8M | $5.5M | $15.1M | $17.9M | $21.0M | $2.6M | $6.4M | $2.5M | $2.5M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $158.1K | $0.00 | $172.0K | |
| Total Liabilities | $18.2M | $8.8M | $4.8M | $5.5M | $15.1M | $20.0M | $22.5M | $2.6M | $6.6M | $3.9M | $3.9M | |
| Stockholders' Equity | $23.3M | $44.6M | $60.9M | $79.6M | $94.7M | $78.1M | $14.8M | $5.6M | $24.3M | $31.2M | $31.2M | |
| Retained Earnings | $17.8M | $35.3M | $53.9M | $66.6M | $61.5M | $12.3M | -$59.5M | -$62.0M | -$70.3M | -$83.0M | -$83.0M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.3M | $12.9M | $6.5M | $10.8M | $2.9M | -$28.1M | -$3.0M | -$13.1M | -$2.7M | -$1.4M | -$4.1M | |
| Capital Expenditure | -$1.1M | -$158.0K | -$283.1K | -$1.2M | -$2.8M | -$2.4M | $0.00 | $0.00 | -$4.00 | $0.00 | -$3.00 | |
| Free Cash Flow | $10.2M | $12.8M | $6.3M | $9.6M | $121.0K | -$30.5M | -$3.0M | -$13.1M | -$2.7M | -$1.4M | -$4.1M | |
| Investing Cash Flow | -$1.1M | -$158.0K | -$277.2K | -$1.2M | -$13.2M | -$8.5M | $89.3K | $11.7M | -$27.0M | -$3.9M | -$30.9M | |
| Financing Cash Flow | -$8.4M | -$8.8M | $271.1K | $10.4M | $10.6M | $18.8M | $3.1M | $0.00 | $29.0M | $15.6M | $44.6M | |
| Issuance of Stock | $0.00 | $0.00 | $0.00 | $9.3M | $11.0M | $18.9M | $3.0M | $0.00 | $27.0M | $19.9M | $46.9M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | -$8.4M | -$671.9K | -$356.5K | $1.1M | $44.1K | -$46.8K | $0.00 | $0.00 | $158.1K | -$2.4M | $0.00 | |
| Stock Based Comp. | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Change in Cash | $4.3M | $4.6M | $5.9M | $18.9M | $2.9M | -$16.8M | -$17.7M | -$1.7M | -$80.4K | $10.0M | $10.0M |
Dilution Tracker
Shares Outstanding
1M
5-Year Share Growth
-47.1%
Stock Issuance (TTM)
$46.9M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.04 | 0.70 | 0.01 | 0.00 | |
| Change vs Prior % | — | 0.0% | -1.2% | -4.6% | 9.7% | 54.7% | 180.6% | -16.7% | 1686.1% | -99.2% | -72.2% | |
| Stock Issuance | $0.00 | $0.00 | $0.00 | $9.3M | $11.0M | $18.9M | $3.0M | $0.00 | $27.0M | $19.9M | $46.9M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 48.7% | 47.7% | 50.4% | 46.8% | 25.4% | 4.1% | 1.8% | — | -518.6% | 16.5% | -1.5% | |
| Operating Margin % | 32.5% | 32.9% | 34.2% | 23.7% | 2.1% | -53.2% | -19.5% | — | -3213.6% | -23.1% | -38.7% | |
| Net Margin % | 27.4% | 28.4% | 29.3% | 19.5% | 1.1% | -55.0% | -307.5% | — | -10519.7% | -87.2% | -138.1% | |
| EBITDA Margin % | 32.7% | 33.1% | 35.2% | 24.7% | 3.4% | -50.7% | -19.2% | — | -2682.4% | -81.8% | -20.7% | |
| FCF Margin % | 19.3% | 20.8% | 9.8% | 14.8% | 0.2% | -34.1% | -12.7% | — | -3731.3% | -9.6% | -27.7% | |
| ROE % | 62.3% | 39.3% | 30.7% | 15.9% | 0.8% | -63.0% | -486.1% | -316.7% | -31.0% | -40.8% | -46.4% | |
| ROA % | 35.0% | 32.8% | 28.5% | 14.9% | 0.7% | -50.5% | -197.4% | -228.7% | -21.2% | -34.5% | -34.5% | |
| ROIC % | 57.2% | 37.8% | 30.1% | 15.4% | 0.6% | -54.4% | -25.8% | -33.2% | -7.3% | -9.7% | -9.7% | |
| R&D / Revenue % | 3.1% | 3.0% | 3.4% | 3.6% | 2.3% | 1.9% | 6.0% | — | 0.0% | 0.0% | 0.0% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 16.0% | 4.0% | 1.8% | 9.9% | 25.2% | -73.9% | -100.0% | 0.0% | 20310.9% | |
| Gross Profit | 0.0% | 13.7% | 9.9% | -5.7% | -40.2% | -79.6% | -88.8% | -191.2% | 2.4% | 750.9% | |
| Operating Income | 0.0% | 17.6% | 7.9% | -29.5% | -90.1% | -3218.3% | 90.4% | 45.9% | 6.6% | -46.8% | |
| Net Income | 0.0% | 20.5% | 7.0% | -32.2% | -93.8% | -6355.5% | -45.8% | 75.4% | 57.4% | -69.2% | |
| EPS (Diluted) | 0.0% | 20.5% | 8.3% | -28.9% | -94.4% | -4141.9% | 48.0% | 70.4% | 97.6% | -20555.8% | |
| Operating Cash Flow | 0.0% | 14.3% | -49.4% | 64.7% | -73.1% | -1068.7% | 89.5% | -341.7% | 79.6% | 47.6% | |
| Free Cash Flow | 0.0% | 25.0% | -51.0% | 53.6% | -98.7% | -25321.1% | 90.3% | -341.7% | 79.6% | 47.6% | |
| R&D Expense | 0.0% | 12.3% | 16.4% | 9.1% | -29.6% | 1.4% | -17.0% | -100.0% | 0.0% | 0.0% | |
| SG&A Expense | 0.0% | 4.3% | 13.6% | 53.6% | 18.4% | 230.9% | -90.0% | -58.1% | -7.4% | 200.3% | |
| Total Assets | 0.0% | 28.6% | 23.0% | 29.6% | 32.5% | -13.6% | -62.7% | -78.7% | 360.1% | 3.7% | |
| Book Value / Share | 0.0% | 91.1% | 38.4% | 36.9% | 11.8% | -48.7% | -93.6% | -55.3% | -68.6% | 13795.9% | |
| Debt | 0.0% | -36.2% | -30.5% | 95.5% | 10.1% | 1.4% | -1.2% | 0.4% | 11.5% | -78.0% | |
| Diluted Shares | 0.0% | 0.0% | -1.2% | -4.6% | 9.7% | 54.7% | 180.6% | -16.7% | 1686.1% | -99.2% |
Valuation
P/E (TTM)At Loss
10Y Low / Med / High5919.66 / 6509.55 / 66866.27
P/S0.17
10Y Low / Med / High0.08 / 1245.80 / 1606564.87
P/B0.00
10Y Low / Med / High0.04 / 1845.63 / 4882.75
EV/EBITDA6.35
10Y Low / Med / High0.71 / 5590.45 / 21834.70
EV/Revenue-0.48
10Y Low / Med / High132.92 / 1758.23 / 1606596.30
P/FCFAt Loss
10Y Low / Med / High7808.77 / 11139.73 / 434450.96
Intrinsic Value Models (per share)
DCF Value
$2110.33
Tangible Book / Share
$10424.75
Net Current Assets / Share
$19.09
Graham Net-Net
$8685.91
Cash / Share
$9520.71
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | 7843.14 | 6509.55 | 6009.01 | 5919.66 | 66866.27 | -242.30 | -405.25 | -492.72 | -15272.32 | -0.10 | -0.00 | |
| P/S Ratio | 2147.95 | 1851.06 | 1758.44 | 1154.42 | 735.56 | 133.12 | 1245.80 | 0.00 | 1606564.87 | 0.08 | 0.17 | |
| P/B Ratio | 4882.75 | 2555.06 | 1845.63 | 943.69 | 554.98 | 152.48 | 1969.45 | 1560.07 | 4738.32 | 0.04 | 0.00 | |
| EV/EBITDA | 6567.83 | 5590.45 | 4990.57 | 4671.01 | 21834.70 | -262.07 | -6473.33 | -4182.35 | -59894.01 | 0.71 | 6.35 | |
| EV/Revenue | 2147.91 | 1850.94 | 1758.23 | 1153.93 | 735.08 | 132.92 | 1245.81 | 0.00 | 1606596.30 | -0.58 | -0.48 |
Analyst Estimates & Quality
Altman Z-Score
-2.04
Distress
Piotroski F-Score
5
Moderate
Forward Estimates (consensus)
| Metric | FY2027 | FY2028 | FY2029 |
|---|---|---|---|
| Revenue | $72.2M | $72.2M | $80.1M |
| Net Income | $12.19B | $12.19B | $4.85B |
| EPS | $2112000.00 | $2112000.00 | $840000.00 |
| # Analysts (EPS) | 1 | 1 | 1 |
Dividends
Frequency
Special
Recent Payments
| Ex-Date | Pay Date | Amount | Frequency |
|---|---|---|---|
| Aug 7, 2020 | Aug 17, 2020 | $0.01 | Special |
Revenue Segments
By Product
| Segment | 2020 | 2025 |
|---|---|---|
| AutomobileMember | $3.4M | — |
| InternetInformationAndAdvertisingMember | $9.2M | — |
| NutraceuticalAndDietarySupplementsMember | $45.4M | — |
| OnlineStoreMember | $13.5M | — |
| Service revenue | — | $2.6M |